Ghana Becomes First Country to Approve Oxford Malaria Vaccine
An Oxford University malaria vaccine has been approved for use in Ghana. It is the first time the shot has received regulatory approval anywhere in the world. Ghana's Food and Drugs Authority has approved the vaccine's use in children aged between five months to three years old.
Adrian Hill, chief investigator of the R21/Matrix-M vaccine programme and director of the university's Jenner Institute, said it marked the "culmination of 30 years of malaria vaccine research at Oxford with the design and provision of a high efficacy vaccine that can be supplied at adequate scale to the countries who need it most."
Ghana is ramping up efforts to combat the mosquito-borne disease that kills over 600,000 each year, most of them children in Africa.
InFocus
-
Neglected Tropical Diseases (NTDs) and malaria have caused suffering to communities worldwide, especially in Africa. NTDs are a diverse group of 20 cond Read more »
-
The Malawi health ministry says it will soon roll out Africa's first malaria vaccine for children under the age of five.
The RTS,S vaccine, which was tested in Gh Read more »
A health worker prepares the malaria vaccine (file photo).